NPPES file of Aug 9, 2026

James T. Love, MD

Allergy Physician · Tulsa, OK

James T. Love, MD is an allergy physician with a practice address in Tulsa, Oklahoma, and NPI 1356322556, issued on Nov 7, 2005. Check the license (Oklahoma 19665, as entered in NPPES) on the Oklahoma Board of Medical Licensure and Supervision; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1356322556
Name
James T. Love
Credential
MD
Primary taxonomy
Allergy Physician 207KA0200X
License number
19665 OK
Self-reported in NPPES; status is on the state search
Practice location
9311 S Mingo RD, Tulsa, OK 74133
Phone
(918) 307-1613
Enumerated
Nov 7, 2005
Record last updated
Mar 14, 2008 (not updated in 18 years: call before relying on the address or phone)
Fax
(918) 307-2454
Medicare enrollment
Enrolled (PECOS I20100329000538); accepts Medicare assignment
Medical or professional school
University Of Connecticut School Of Medicine, 1991
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 9311 S Mingo RD

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Karen Arnold, ARNPFamily Nurse Practitioner1225130024
  2. Kathryn Brown, M.D.Clinical & Laboratory Immunology (Allergy & Immunology) Physician1447299151
  3. Vanessa Byers, ARNPPediatric Nurse Practitioner1285716795
  4. Todd Coleman, ARNPPediatric Nurse Practitioner1427143502
  5. David Hurewitz, MDAllergy Physician1760463947
  6. Lodie Naimeh, MDAllergy Physician1265413462

Verify James T. Love in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersOklahoma Board of Medical Licensure and Supervision
    Search for license 19665
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Oklahoma license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

55% fewer Medicare Part D claims than the average allergy physician in 2024

341 Medicare Part D claims for 61 beneficiaries, against an average of 750 among the 645 providers of this specialty who prescribed in Part D. Brand-name drugs were 43% of claims.

  1. James Love341
  2. Specialty average750

Most prescribed

  1. Ipratropium Bromide46 claims
  2. Trelegy Ellipta39 claims
  3. Montelukast Sodium29 claims
  4. Epinephrine22 claims
  5. Symbicort20 claims
  6. Azelastine Hcl18 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $1,484.14

67 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 502 providers of this specialty with any payment received $9,080.33 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. James Love$1,484.14
  2. Specialty average$9,080.33

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Allergy Clinic OF Tulsa IncTulsa, OK

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Allergy Physician providers in Oklahoma

There are 8 allergy physician records in Oklahoma.

The 7 allergy physician records with the nearest ZIP codes

  1. David Hurewitz, MDTulsa, OK 741331760463947
  2. Lodie Naimeh, MDTulsa, OK 741331265413462
  3. Timothy Nickel, MDTulsa, OK 741331154302354
  4. Jane Purser, MDTulsa, OK 741331376524561
  5. Martha Tarpay, MDOklahoma City, OK 731201306808928
  6. Claire Atkinson, MDOklahoma City, OK 731041255868485
  7. Gregory Metz, M.D.Oklahoma City, OK 731041174797062

Common questions

What is James T. Love, MD's NPI number?

James T. Love, MD's National Provider Identifier (NPI) is 1356322556, issued on Nov 7, 2005. An NPI identifies a provider in billing; it is not a license.

Where is James T. Love, MD located?

The NPPES record lists a practice address at 9311 S Mingo RD, Tulsa, OK, 74133. Phone: (918) 307-1613. Providers update this record themselves, so call before visiting.

How can I verify James T. Love, MD's license?

NPPES lists Oklahoma license number 19665, as entered by the provider. Search the Oklahoma Board of Medical Licensure and Supervision at https://www.okmedicalboard.org/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does James T. Love, MD prescribe under Medicare Part D?

In 2024, James T. Love, MD had 341 Medicare Part D claims for 61 beneficiaries; the average among allergy physician prescribers was 750. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.